Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Colorectal Cancer Screening Market, by Type
1.4.2 North America Colorectal Cancer Screening Market, by End-user
1.4.3 North America Colorectal Cancer Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Colorectal Cancer Screening Market by Type
5.1 North America Colonoscopy Market by Country
5.2 North America Stool-based Market by Country
5.3 North America Colorectal Cancer Screening Market by Stool-based Type
5.3.1 North America Fecal Immunochemical Test (FIT) Market by Country
5.3.2 North America Fecal Occult Blood Test (FOBT) Market by Country
5.3.3 North America Stool-DNA Test Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Colorectal Cancer Screening Market by End-user
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Clinical Laboratories Market by Country
6.3 North America Diagnostic Imaging Centres Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Colorectal Cancer Screening Market by Country
7.1 US Colorectal Cancer Screening Market
7.1.1 US Colorectal Cancer Screening Market by Type
7.1.1.1 US Colorectal Cancer Screening Market by Stool-based Type
7.1.2 US Colorectal Cancer Screening Market by End-user
7.2 Canada Colorectal Cancer Screening Market
7.2.1 Canada Colorectal Cancer Screening Market by Type
7.2.1.1 Canada Colorectal Cancer Screening Market by Stool-based Type
7.2.2 Canada Colorectal Cancer Screening Market by End-user
7.3 Mexico Colorectal Cancer Screening Market
7.3.1 Mexico Colorectal Cancer Screening Market by Type
7.3.1.1 Mexico Colorectal Cancer Screening Market by Stool-based Type
7.3.2 Mexico Colorectal Cancer Screening Market by End-user
7.4 Rest of North America Colorectal Cancer Screening Market
7.4.1 Rest of North America Colorectal Cancer Screening Market by Type
7.4.1.1 Rest of North America Colorectal Cancer Screening Market by Stool-based Type
7.4.2 Rest of North America Colorectal Cancer Screening Market by End-user
Chapter 8. Company Profiles
8.1 Novigenix SA
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Eiken Chemical Co., Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Clinical Genomics Pathology, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Exact Sciences Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Epigenomics AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 BioMerieux S.A.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Olympus Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.4.1 Acquisition and Mergers:
8.9.5 SWOT Analysis
8.10. Fujifilm Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Geographical Expansions:
8.10.6 SWOT Analysis
Unique Offerings 